Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 22 Jun 2026 for Veracyte, INC.. Read the official filing
Filing timeline
BuySaleKarin Eastham
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Karin Eastham: trading record in brief
Karin Eastham, listed as senior executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Veracyte, Inc., Nektar Therapeutics and Personalis, Inc. In total, 32 filings cover trades dated from 25 February 2021 to 18 June 2026.
Every open-market trade on record is a sale: 11 sales worth €1.1M. The amount is not disclosed for 2 filings. Besides market trades, the filings include 11 share grants and 10 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The latest filing, published on 22 June 2026, reports an open-market sale in Veracyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Karin Eastham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
3,200 sharesCommon StockSEC:0001231845-26-000006:0
529 sharesCommon StockSEC:0001231845-26-000006:1
5,272 sharesCommon StockSEC:0001231845-26-000004:0
6,250 shares0Common StockSEC:0001231845-26-000001:0
10,000 shares@ US$7.944.1% of flowCommon StockSEC:0001231845-25-000007:0
9,674 shares@ US$40.023921.1% of flowCommon StockSEC:0001231845-25-000005:0
9,321 shares0Common StockSEC:0001384101-25-000099:0
4,590 shares@ US$26.6648.4% of flowCommon StockSEC:0001384101-25-000080:0
10,000 shares@ US$5.283.9% of flowCommon StockSEC:0001384101-25-000002:0
1,600 shares@ US$36.76634.2% of flowCommon StockSEC:0001384101-24-000168:0
7,500 shares@ US$25.0013.0% of flowCommon StockSEC:0001384101-24-000111:0
11,473 shares0Common StockSEC:0001384101-24-000100:0
3,870 shares@ US$20.595.6% of flowCommon StockSEC:0001384101-24-000091:0
2,500 shares@ US$10.411.8% of flowCommon StockSEC:0001384101-24-000085:0
10,000 shares@ US$13.199.3% of flowCommon StockSEC:0001384101-24-000047:0
9,674 shares0Common StockSEC:0001384101-23-000125:0
18,750 shares@ US$12.1216.2% of flowCommon StockSEC:0001384101-23-000042:0
10,000 shares@ US$12.128.6% of flowCommon StockSEC:0001384101-23-000020:0
35,000 shares@ US$1.1043.8% of flowCommon StockSEC:0001062993-23-001007:0
10,200 shares0Common StockSEC:0001209191-22-050814:0
21,267 shares@ US$3.61100.0% of flowCommon StockSEC:0001209191-22-049960:0
14,731 shares0Common StockSEC:0001384101-22-000097:0
10,770 shares0Common StockSEC:0001209191-22-030771:0
35,000 shares@ US$1.410.0055% mcap100.0% of flowCommon StockSEC:0001062993-22-010624:0
5,000 shares@ US$12.120.0017% mcap10.8% of flowCommon StockSEC:0001384101-21-000184:0
25 of 32 declarations
